Molecular expression of myostatin and MyoD is greater in double-muscled than normal-muscled cattle fetuses. Am J Physiol Regulatory Integrative Comp Physiol 280: R1488-R1493, 2001.-Excessive muscling in double-muscled cattle arises from mutations in the myostatin gene, but the role of myostatin in normal muscle development is unclear. The aim of this study was to measure the temporal relationship of myostatin and myogenic regulatory factors during muscle development in normal (NM)-and double-muscled (DM) cattle to determine the timing and possible targets of myostatin action in vivo. Myostatin mRNA peaked at the onset of secondary fiber formation (P Ͻ 0.001) and was greater in DM (P Ͻ 0.001) than in NM. MyoD expression was also elevated throughout primary and secondary fiber formation (P Ͻ 0.001) and greater in DM (P Ͻ 0.05). Expression of myogenin peaked later than MyoD (P Ͻ 0.05); however, it did not differ between NM and DM. These data show that myostatin and MyoD increase coincidentally during formation of muscle fibers, indicating a coordinated role in the terminal differentiation and/or fusion of myoblasts. Myostatin mRNA is also consistently higher in DM than NM, suggesting that a feedback loop of regulation is also disrupted in the myostatin-deficient condition.
-Excessive muscling in double-muscled cattle arises from mutations in the myostatin gene, but the role of myostatin in normal muscle development is unclear. The aim of this study was to measure the temporal relationship of myostatin and myogenic regulatory factors during muscle development in normal (NM)-and double-muscled (DM) cattle to determine the timing and possible targets of myostatin action in vivo. Myostatin mRNA peaked at the onset of secondary fiber formation (P Ͻ 0.001) and was greater in DM (P Ͻ 0.001) than in NM. MyoD expression was also elevated throughout primary and secondary fiber formation (P Ͻ 0.001) and greater in DM (P Ͻ 0.05). Expression of myogenin peaked later than MyoD (P Ͻ 0.05); however, it did not differ between NM and DM. These data show that myostatin and MyoD increase coincidentally during formation of muscle fibers, indicating a coordinated role in the terminal differentiation and/or fusion of myoblasts. Myostatin mRNA is also consistently higher in DM than NM, suggesting that a feedback loop of regulation is also disrupted in the myostatin-deficient condition. myogenic regulatory factor; bovine; myoblast; myofiber THE CONDITION OF DOUBLE MUSCLING (DM) in Belgian Blue cattle stems from an 11-bp deletion in the myostatin gene, also known as GDF-8, that gives rise to a premature stop codon and a severely truncated myostatin protein (7, 11) . On the basis of structural similarities, it appears that myostatin belongs to the greater transforming growth factor-␤ (TGF-␤) family and has been identified as an important negative regulator of muscle development in a mouse model of gene deletion (16) . In the absence of myostatin, the skeletal musculature of mice is two to three times greater in mass than that of wild-type mice (16) . In parallel with this, the skeletal musculature of DM Belgian Blue cattle is ϳ20% greater than in normal-muscled (NM) cattle (21) .
The enlarged musculature of the myostatin-deficient mouse results from effects on both early (hyperplasia) and late (hypertrophy) myogenic processes (16) , and mRNA is expressed at different levels in various postnatal muscles (11, 16) . Such observations suggest that myostatin may influence muscle development at a number of stages. The aim of this experiment was to measure the fetal expression of myostatin in relation to skeletal muscle-specific transcription factors (MRFs) in normal muscle and the myostatin-deficient DM condition, to help determine a role for myostatin in the physiology of muscle formation.
MATERIALS AND METHODS

Animals.
Fetuses with an expected DM phenotype were produced using standard superovulation and embryo transfer techniques (9) . Donor Belgian Blue cows were inseminated with semen from Belgian Blue bulls. Embryos were recovered 7 days after insemination and transferred to Hereford ϫ Friesian recipient heifers. Fetuses with an expected NM phenotype were produced either by artificial insemination of heifers from the Hereford ϫ Friesian recipient herd or by embryo transfer into recipients from this herd. Using in vitro techniques (15), we generated embryos from ovaries collected from beef and dairy cows of NM phenotype. Semen used to generate NM fetuses was from Friesian bulls. The recipients were grazed in a single herd and slaughtered at 50, 70, 90, 120, 160, 210, and 260 days of gestation.
Three to seven fetuses were produced at every gestational age for each breed. At slaughter, blood samples were taken from the fetuses by cardiac puncture, and hindlimbs (50-90 days) or M. semitendinosus (120-260 days) was dissected and frozen in liquid nitrogen (n ϭ 53). Approval for this study was obtained from the Animal Ethics Committee of Ruakura Research Center. In cattle, myoblast fusion and formation of primary muscle fibers are initiated at 39 days of gestation (17) , and the formation of secondary fibers is initiated by 90 days of gestation (18) .
RNA isolation and RT-PCR. Total RNA was isolated from hindlimb and muscle samples using Trizol (GIBCO BRL, Grand Island, NY) according to the manufacturer's instructions and treated with RNAse-free DNAse 1 (Roche Diagnostics, Indianapolis, IN). First-strand cDNA was synthesized in a 20-l RT reaction from 2 g of total RNA, using a Superscript Preamplification kit (GIBCO BRL), and semiquantitative, multiplex RT-PCR was carried out with 2 l of the RT reaction as template. Additional RT reactions were produced for each RNA sample (n ϭ 53) as required. Pairs of primers for ubiquitin-activating enzyme (UAE) were included in PCR reactions as an internal control to correct for cDNA and loading differences in the Southern analysis. All PCR reactions included primers for both the candidate and control gene, apart from myostatin, which was amplified independently from UAE. In this situation, reactions were carried out at the same time, with duplicates of cDNA template from the same stock and differing only by the addition of primers. Q-solution (20%, QIAGEN, Valencia, CA) was also added to the PCR reaction for MyoD/UAE. PCR conditions were optimized for detection within the linear range (Table 1 , Fig. 1 ). Sequences of PCR fragments have been submitted to GenBank for bovine myogenin (GenBank Accession Number AF091714), bovine MyoD (GenBank Accession Number AF093675), and bovine UAE (GenBank Accession Number AF093676). The amplification parameters were denatured at 94°C for 1 min, annealed at the temperatures outlined in Table 1 for 1 min, followed by 72°C for 1 min for the appropriate number of cycles. An extension period of 72°C for 5 min was the final step. Primer concentrations for each reaction were 20 pmol for myostatin and UAE, 30 pmol for myogenin, and 40 pmol for MyoD.
Southern analysis. PCR samples were run on a 2% agarose gel, transferred overnight onto Hybond Nϩ membrane (Amersham, Bucks, UK), and immobilized by ultraviolet crosslinking (Stratalinker, Stratagene, La Jolla, CA). Membranes were prehybridized at 42°C in 5ϫ sodium chloride-sodium citrate (SSC), 50% formamide, and 5ϫ Denhardt's solution with 1% SDS and 0.25 mg/ml of salmon sperm DNA for 2 h, then hybridized in the same solution overnight with the appropriate random-primed, 32 P-labeled cDNA probes. After hybridization, membranes were washed three times at 50°C for 15 min each with 2ϫ SSC and 0.1% SDS. They were exposed against X-Omat AR10 film (Eastman Kodak, Rochester, NY) for varying periods of time from 1 to 48 h at Ϫ80°C (Fig. 1) . For quantitation, radiographs were scanned with a Bio-Rad 670 Densitometer, and band densities were estimated using Molecular Analyst (Bio-Rad Laboratories, Hercules, CA).
Northern analysis. Differences in expression of genes, as determined by semiquantitative PCR, between NM and DM underwent further measurement by Northern analysis. A limited number of RNA samples from 120-day samples of muscle (n ϭ 2) from NM and DM were used for Northern Myostatin  5Ј-GGTATTTGGCAGAGTATTGAT-3Ј  513  50  14  5Ј-GTCTACTACCATGGCTGGAAT-3Ј  MyoD  5Ј-GCTATATCGAAGGCCTGCA-3Ј  497  42  18  5Ј-TCAGAGCACCTGGTAAATC-3Ј  Myogenin  5Ј-CTACAAGCTTGTCCACCTC/TCAGGGC-3Ј  530  50  18  5Ј-GAC/GGTAAGCTTGTGCAGA/GTTGTGG-3Ј  UAE  5Ј-TTGGATCCCCACCA/TGAGAAA/GTCCATCCC-3Ј  264  42/50 14/18 5Ј-TTGAATTCGGC/TAGGCCCAA/GGTCACA/GCA-3Ј Sequences were obtained from the following GenBank accession numbers: bovine myostatin, AF019761; ovine MyoD, X62102; murine myogenin, M95800; and ovine ubiquitin-activating enzyme, AF088855.
hybridization with 32 P-labeled cDNA probes made by PCR amplification of the entire coding sequence of myostatin or MyoD and a 32 P end-labeled oligonucleotide probe for 28S ribosomal RNA (AACGATCAGAGTAGTGGTATTTCACC). RNA (12 g for myostatin and 20 g for MyoD) was run on a 1.2% formaldehyde-agarose gel, transferred, and cross-linked as described earlier. Membranes were prehybridized at 60°C in Church and Gilbert buffer (1 mM EDTA, 0.5 M NaHPO4, pH 7.2, 7% SDS) for 2 h, then hybridized in the same solution overnight with the appropriate 32 P-labeled probe. After hybridization, membranes were washed as previously described, then washed with 1ϫ SSC and 0.1% SDS at 50°C for 15 min. Membranes were exposed against X-Omat AR10 for varying periods of time; band densities on radiographs were estimated as described earlier and then stripped and rehybridized with the 32 P end-labeled 28S probe for estimation of RNA loading.
Statistics. For each gene of interest, an average optical density value for UAE was calculated, and individual UAE values were expressed as a percentage of the average. Values of optical density for the specific gene of interest were then multiplied by the UAE percentages and used in an ANOVA. Data were log-transformed when not normal in distribution, and age and breed were tested as main effects using ANOVA. Comparisons were also made between the breeds at each gestational age.
RESULTS
Results are presented with the significance of main effects from ANOVA indicated in Figs. 2 and 3 . Differences between NM and DM at each gestational age are indicated by asterisks if significant.
Skeletal and muscle growth. During fetal development, there was no difference in skeletal growth between DM and NM fetuses, as determined by measurement of crown-rump length ( Fig. 2A) . However, in musculus semitendinosus that was dissected from animals of 120 days' gestation and older, muscle weights were always greater in DM (Fig. 2B , P Ͻ 0.001).
Semiquantitative RT-PCR and Southern analysis. Expression of myostatin mRNA (Fig. 3A) varied with developmental age (P Ͻ 0.001) and showed a peak of expression at 90 days of gestation. Levels were also greater in DM than in NM (P Ͻ 0.001). Myostatin expression returned to relatively low levels in NM at 120 days, whereas expression in DM remained elevated until 210 days. By 260 days, there was no difference between the breeds.
Expression of MyoD mRNA varied significantly throughout muscle development (Fig. 3B , P Ͻ 0.001), being relatively high until 120 days, then falling to low levels. Overall, expression was also greater in DM than in NM (P Ͻ 0.05). At 160 and 210 days, individual levels of mRNA were greater for DM than NM (P Ͻ 0.001). Levels of myogenin mRNA increased until 120 days and then declined (Fig. 3C , P Ͻ 0.05) and showed no difference between NM and DM.
Northern analysis. A comparison of NM and DM expression at 120 days (Fig. 4) supports the observations made by RT-PCR with increased expression of myostatin and MyoD in DM.
DISCUSSION
The final phase of determining numbers of muscle fibers in a muscle occurs during the terminal differentiation and fusion of proliferating myoblasts into primary and secondary myotubes and myofibers. It is generally considered that heterogeneous populations of myoblasts separately give rise to successive generations of muscle fibers (20) . In cattle, differentiation of early myoblasts into primary myotubes in the hindlimb is initiated at 39 days of gestation (17), whereas differentiation of late myoblasts into secondary myofibers is established at 90 days (18). Numbers of muscle fibers then increase until 240 days of gestation (18), which is ϳ40 days before birth (4) . The condition of DM in cattle is typified by an increase in the number of muscle fibers in all skeletal muscles and increased mass in those muscles that are located superficially on the body (21) . Recently, it has been established that DM in Belgian Blue cattle arises from a deletion in the myostatin gene, which gives rise to the production of a truncated protein (11) .
Peak levels of myostatin expression in NM coincide with established primary fiber development and the onset of secondary fiber formation in the hindlimb. Increased expression is not extended throughout 120 to 210 days suggesting that myostatin is unlikely to be a principal regulatory control of the ongoing development and maturation of secondary myofibers. Other members of the TGF-␤ family, TGF-␤s1-3, are differentially expressed in both developing skeletal muscle and transformed myoblasts (3, 14) , and the pattern of myostatin expression that we report is most similar to that of TGF-␤1. The effects of TGF-␤ on myoblasts are variable, promoting differentiation when myoblasts are relatively mature (25) , otherwise inhibiting myoblast proliferation (1). It is tempting to speculate that myostatin may also differentially affect myoblasts, possibly stimulating the induction of terminal differentiation and fusion of early myoblasts while downregulating proliferation in late myoblasts. Such a suggestion has support from other studies that demonstrate that TGF-␤ has variable inhibitory effects on proliferation of early and late myoblasts (6) and fetal and postnatal satellite cells (10) .
The expression of myostatin mRNA in DM is similar to NM, but levels are relatively higher throughout myogenesis. A number of possibilities present themselves as explanations for the elevated expression of mutant myostatin. A functional myostatin protein is almost certainly not produced in DM (11), so a component of feedback regulation of myostatin expression may be missing. The regulatory component may be myostatin itself as for TGF-␤ (12, 14) . Alternatively, an intracellular/autocrine feedback loop may operate, as suggested for interactions between insulin-like growth factors and TGF-␤s (3), or an endocrine growth factor stimulated by myostatin may then regulate expression of myostatin mRNA. A further possibility is that breed differences in the cis or trans factors regulating myostatin mRNA are reflected in relative levels of expression.
In NM, the greatest levels of MyoD mRNA expression occurred at 70-120 days, during terminal differentiation of early and late myoblasts. MyoD and myogenin are both integral components of the process of myoblast withdrawal from proliferation and subsequent commitment to differentiation and myofiber formation. Proliferating myoblasts contain basal amounts of MyoD and myogenin (22, 25) , and induction of MyoD is associated with the arrest of proliferation in cells (8) . However, coexpression of myogenin and p21, which are both MyoD dependent (8, 22) , is required to completely arrest the cell cycle (2) . These studies indicate that not only proliferation, but cell cycle withdrawal, is a discrete process from further myoblast differentiation and that MyoD is likely to regulate downstream events in the myogenic cascade. Developmental changes in the NM expression of myogenin mRNA were broadly similar to the pattern for MyoD, as might be expected if the expression of myogenin during differentiation is dependent on earlier induction of MyoD. Our data fit well with culture studies where myogenin expression is low in proliferating myoblasts, peaks during differentiation, and declines in myofibers (22) .
In DM, MyoD mRNA was increased relative to NM. This difference may be a consequence of myostatin deficiency, having arisen either as a result of increased numbers of myoblasts from DM expressing MyoD at the same developmental age or a greater induction of MyoD above a critical threshold level in a population of terminally differentiating myoblasts. The manner by which myostatin might regulate MyoD expression may be similar to the action of TGF-␤s on MyoD and myogenin. TGF-␤ treatment of myogenic cultures results in an inhibition of differentiation that is associated with reduced expression of MyoD mRNA (23) . Although the downstream cascade of events is likely to include a reduction of MyoD-stimulated expression of myogenin, there is also a direct inhibitory effect of TGF-␤ on the transcriptional activity of both myogenin and MyoD (5, 13) . The transition of myoblasts from states of proliferation to differentiation is delayed in MyoD-deficient satellite cells (19, 24) , illustrating the importance of tightly regulated and coordinated expression of MyoD during terminal differentiation and myofiber formation.
In conclusion, we propose that one role played by myostatin in normal muscle development is to regulate MyoD expression during terminal differentiation of primary and secondary myoblasts. In the myostatindeficient condition, it is likely that the elevated expression of MyoD promotes the increased formation of muscle fibers throughout fetal myogenesis. Furthermore, we have also provided evidence that there is a feedback loop for regulation of myostatin expression in NM animals, the pathway of which is currently unknown.
Perspectives
The results from this study indicate that myostatin is associated with myoblasts withdrawing from the proliferative cycle, preceding the formation of muscle fibers. Withdrawal of myoblasts from the cell cycle also involves the myogenic regulatory factors MyoD and myogenin, and the evidence presented suggests a direct or indirect interaction between myostatin and MyoD. Myostatin may be considered as a modifier of myoblast activity, as it is not essential for the formation of functional muscles during gestation and the number of muscle fibers is increased in the absence of myostatin. Myostatin appears to modulate fetal muscle development by inhibiting myoblast withdrawal from the proliferative cycle and terminal differentiation and so appears to be one of the long sought-after inhibitors of growth of specific tissues and organs.
Future research will undoubtedly focus on the pathways by which myostatin controls myoblast and satellite cell division and how this interacts with the biologically more significant myogenic factors that determine whether or not muscle formation takes place.
